Scientists at Pompeu Fabra University discovered that mice recovering from acute viral infections experienced prolonged immune system impairments that could be prevented by prior vaccination.
The research, published in Cell Death & Disease by investigators at the Infection Biology Laboratory, indicates that eliminating a pathogen does not instantly restore normal immune function. Instead, viral infections can leave behind persistent structural changes in the spleen and weaken the body’s adaptive defenses against subsequent health threats.
Immune Suppression and Splenic Fibrosis Persist After Infection
- Persistent Immune Suppression: Eliminating a virus does not always mean the immune system instantly returns to normal, as underlying structural damage can linger.
- Splenic Fibrosis: Researchers observed scar-like tissue buildup in the spleen—the organ responsible for coordinating immune defenses—which hindered T-cell activation.
- Vaccination Protection: Animals that received a vaccine prior to infection maintained normal spleen structures and fully functional T-cell responses.
Persistent Immune Dysfunction After Acute Viral Infections
Most people consider common viral infections like colds or stomach bugs to be temporary illnesses that resolve completely once symptoms disappear. However, researchers investigated whether harmful effects continue long after clinical recovery.
Andreas Meyerhans, an ICREA research professor at UPF who led the research, stated, “there is a general perception that an acute viral infection is a relatively minor and transient event: once the virus is controlled and the symptoms have resolved, the body has fully recovered and is back to normal. But this view may underestimate consequences that are not immediately visible and can persist long after the infection itself has resolved,” ScienceDaily reported.
The research team traced these lingering effects to changes in the spleen. As the immune system fought the pathogen, the organ developed fibrosis, involving a buildup of scar-like tissue that disrupted the positioning of immune cells.
Splenic Structural Damage Interferes with T-Cell Activation
The structural changes inside the spleen interfered with the cellular interactions necessary to activate T cells. These specialized cells belong to adaptive immunity and help recognize and destroy infected cells.
Because of this disruption, the mice remained less capable of launching effective immune responses when exposed to new challenges. Even though the original infection had been brought under control, their overall defense mechanisms functioned poorly.
“The infection can be controlled, but that does not necessarily mean that the host has fully recovered,” said Dr. Paula Cebollada Rica, first author of the study, told ScienceDaily. “Our findings show that the immune-related consequences of an acute viral infection can persist beyond the period in which the virus is detectable, leaving the animals in an immunocompromised state.”
Vaccination Preserves Immune Function and Prevents Spleen Damage
After identifying these long-term alterations, the scientists evaluated whether vaccination could prevent them. Mice that received a vaccination prior to infection did not develop the spleen damage or immune dysfunction observed in the unvaccinated group.
Their spleens maintained normal tissue architecture, and their T cells continued to function at levels comparable to those of animals that had never been infected. This finding indicates that vaccination offers an additional layer of protection beyond preventing acute disease.
“Vaccinated animals did not experience T-cell dysfunction or splenic alterations after recovering from an acute viral infection,” Cebollada Rica explained to ScienceDaily. “This means that vaccination not only prevented the disease resulting from the acute infection but also preserved the immune system’s ability to cope with new challenges.”
Broader Public Health Implications
The findings broaden the recognized benefits of vaccination by highlighting a form of protection that remains less apparent during routine clinical care. Although the data derive from a mouse model and require human clinical validation, they raise important questions regarding long-term immune health.
Meyerhans emphasized the value of empirical evidence in public health communication, telling ScienceDaily that “the benefits of vaccination highlighted by this research are important not only for healthcare, but also for how we communicate the value of vaccination to the population at large.”
He added, “It is important that people are aware of the broader protection that vaccination can provide and continue to trust in vaccines as one of the most effective tools to prevent diseases. Put simply, vaccines provide strong health benefits at a relatively low cost to society.”
Comparing Splenic Architecture and T-Cell Function in Vaccinated and Unvaccinated Groups
| Parameter | Unvaccinated Post-Infection Group | Vaccinated Post-Infection Group |
|---|---|---|
| Viral Clearance | Achieved | Achieved |
| Splenic Architecture | Altered (Fibrosis & Scarring) | Normal Structure Preserved |
| T-Cell Function | Impaired Activation | Fully Functional |
| Secondary Challenge Response | Compromised | Maintained |
References
- Cebollada Rica, P., et al. Research findings on viral infection and immune system recovery. Cell Death & Disease.
- Pompeu Fabra University Infection Biology Laboratory. Investigations on splenic fibrosis and adaptive immunity.
